In-silico studies of Novel triazole derivatives as inhibitor of 14α demethylase CYP51

Rao, Shrusti and Bhat, Varadaraj G and Fathima, Fajeelath and Kumar, Santosh and Verma, Ruchi (2020) In-silico studies of Novel triazole derivatives as inhibitor of 14α demethylase CYP51. Research Journal of Pharmacy and Technology, 13 (12). pp. 5806-5810. ISSN 0974-3618

[img] PDF
10658 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (375kB) | Request a copy


An antifungal agent is a drug that eliminates fungal pathogens selectively from host with negligible toxicity to the host. Antifungal agents are classified into classes like antibiotics, antimetabolite, azole, and allyl amine. In this present work, the binding mode of novel designed triazole analogues with CYP51 has been investigated by flexible molecular docking. The molecular modeling, which gives the utilization of structural information of CYP51 can enhance the discovery of novel antifungal agents. Further in silico studies were performed in order to see their drug likeness properties and possible mode of interaction with target protein residue. Molecular docking of novel molecules was done by Schrodinger software using following steps like protein preparation, ligand preparation, grid generation, molecular docking. The protein PDB selected was 5V5Z. AZ3 analogue showed the best dock score. The docking value varied from -2.578 to-8.19 for the designed ligands. All the molecules showed good ADME properties and followed Lipinski rule of five. The designed molecules can serve as a lead for future antifungal drug discovery

Item Type: Article
Uncontrolled Keywords: Molecular docking; Triazole; Antifungal
Subjects: Pharmacy > MCOPS Manipal > Pharmaceutical Chemistry
Depositing User: KMC Library
Date Deposited: 01 Jun 2021 10:30
Last Modified: 01 Jun 2021 10:30

Actions (login required)

View Item View Item